Literature DB >> 8058343

Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA.

J Devlin1, A J Keen, M A Knowles.   

Abstract

We have screened 165 cases of primary transitional cell carcinoma of the bladder for loss of heterozygosity of markers on chromosome 9. High density deletion mapping was then carried out on a panel of 16 tumours with partial deletions of 9p using 15 microsatellite markers. Seven tumours had hemizygous deletions which included small interstitial losses and large terminal deletions. Homozygous deletions of one or more markers were identified in the remaining 9 tumours. By comparing the limits of hemi- and homozygous deletions in these tumours we have defined a single common region of 2cM flanked by IFNA and D9S171.

Entities:  

Mesh:

Year:  1994        PMID: 8058343

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  The prognostic value of FGFR3 mutational status for disease recurrence and progression depends on allelic losses at 9p22.

Authors:  Guillaume Ploussard; Hany Soliman; Francis Dubosq; Paul Méria; Jérôme Vérine; François Desgrand-Champs; Hugues Dethé; Pierre Mongiat-Artus
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

2.  Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification.

Authors:  Joanne S Aveyard; Margaret A Knowles
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

3.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

Review 4.  Molecular pathogenesis of bladder cancer.

Authors:  Margaret A Knowles
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

5.  Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.

Authors:  A A van Tilborg; L E Groenfeld; T H van der Kwast; E C Zwarthoff
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  Establishment and characterization of pleomorphic adenoma cell systems: an in-vitro demonstration of carcinomas arising secondarily from adenomas in the salivary gland.

Authors:  Satoshi Maruyama; Jun Cheng; Susumu Shingaki; Takashi Tamura; Shuichi Asakawa; Shinsei Minoshima; Yoshiko Shimizu; Nobuyoshi Shimizu; Takashi Saku
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

7.  Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.

Authors:  Woo Jeong Yoo; Seung Ho Cho; Youn Soo Lee; Gyeong Sin Park; Min Sik Kim; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

8.  Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.

Authors:  K L Marsh; J M Varley
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

9.  Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

Authors:  J M Bartlett; A D Watters; S A Ballantyne; J J Going; K M Grigor; T G Cooke
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.

Authors:  J Devlin; P A Elder; H Gabra; C M Steel; M A Knowles
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.